Restoration of Facial Form and Function After Severe Disfigurement from Burn Injury by a Composite Facial Allograft

Composite facial allotransplantation is emerging as a treatment option for severe facial disfigurements. The technical feasibility of facial transplantation has been demonstrated, and the initial clinical outcomes have been encouraging. We report an excellent functional and anatomical restoration 1 year after face transplantation. A 59‐year‐old male with severe disfigurement from electrical burn injury was treated with a facial allograft composed of bone and soft tissues to restore midfacial form and function. An initial potent antirejection treatment was tapered to minimal dose of immunosuppression. There were no surgical complications. The patient demonstrated facial redness during the initial postoperative months. One acute rejection episode was reversed with a brief methylprednisolone bolus treatment. Pathological analysis and the donor's medical history suggested that rosacea transferred from the donor caused the erythema, successfully treated with topical metronidazol. Significant restoration of nasal breathing, speech, feeding, sensation and animation was achieved. The patient was highly satisfied with the esthetic result, and regained much of his capacity for normal social life. Composite facial allotransplantation, along with minimal and well‐tolerated immunosuppression, was successfully utilized to restore facial form and function in a patient with severe disfigurement of the midface.

[1]  Bohdan Pomahac,et al.  Vascular Considerations in Composite Midfacial Allotransplantation , 2010, Plastic and reconstructive surgery.

[2]  M. Siemionow,et al.  Advances in the development of experimental composite tissue transplantation models , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  J. Fung,et al.  Near-total human face transplantation for a severely disfigured patient in the USA , 2009, The Lancet.

[4]  Shuzhong Guo,et al.  Human facial allotransplantation: a 2-year follow-up study , 2008, The Lancet.

[5]  F. Bellivier,et al.  Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study , 2008, The Lancet.

[6]  R. Alloway,et al.  Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. , 2008, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[7]  A. Sirigu,et al.  Outcomes 18 months after the first human partial face transplantation. , 2007, The New England journal of medicine.

[8]  Jean Kanitakis,et al.  Clinicopathologic features of graft rejection of the first human hand allograft , 2003, Transplantation.

[9]  A. Kirk,et al.  Composite tissue allotransplantation: classification of clinical acute skin rejection. , 2005, Transplantation.

[10]  M. Berg,et al.  An epidemiological study of rosacea. , 1989, Acta dermato-venereologica.